MoneyWorks4Me

Desh Rakshak Aushdhalaya submits statement of deviation or variation

19 Oct 2023 Evaluate
Desh Rakshak Aushdhalaya has informed that it enclosed statement of deviation in public issue, right issue, preferential issue, etc. pursuant to Regulation 32 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the purpose of making disclosure to the stock exchange.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1844.90
Dr. Reddys Labs. 1217.35
Cipla 1391.95
Lupin 2065.00
Zydus Lifesciences 1223.95
View more..